Current through Register Vol. 51, No. 3, September 1, 2024
RELATES TO:
KRS
315.0351,
315.121,
315.191(1)(a),
315.400,
315.4102,
315.4104,
315.4106,
315.4108,
315.4110,
21 U.S.C.
360eee -eee-4
NECESSITY, FUNCTION, AND CONFORMITY:
KRS
315.191(1)(a),
315.4102,
315.4104,
315.4106,
315.4108, and
315.4110 authorizes the board to
promulgate administrative regulations to regulate third-party logistics
providers. This administrative regulation establishes requirements for the
regulation of third-party logistics providers
Section 1. Definitions.
(1) "Board" means the Board of
Pharmacy.
(2) "Component" means any
raw material, ingredient, or article intended for use in the manufacture of a
drug and drug-related device.
(3)
"Distribution" or "distribute" is defined by
KRS
315.400(5).
(4) "Drug sample" means a unit of a
prescription drug that is not intended to be sold and is intended to promote
the sale of the drug.
(5)
"Illegitimate product" is defined by
KRS
315.400(11).
(6) "Product" means a prescription drug in a
finished dosage form for administration to a patient without substantial
further manufacturing, such as capsules, tablets, and lyophilized products
before reconstitution.
(7) "Suspect
product" means a component, prescription drug, or drug-related device for which
there is a reason to believe that the component, prescription drug, or
drug-related device:
(a) Is potentially
counterfeit, diverted, or stolen;
(b) Is potentially intentionally adulterated
so that the component, prescription drug, or drug-related device may result in
serious adverse health consequences or death to humans or animals;
(c) Is potentially the subject of a
fraudulent transaction; or
(d)
Appears otherwise unfit for distribution so that the component, prescription
drug, or drug-related device may result in serious adverse health consequences
or death to humans or animals.
(8) "Third-party logistics provider" is
defined by KRS
315.400(18).
Section 2. Requirements.
(1) A third-party logistics provider
providing services in the Commonwealth, including distributing into the
Commonwealth, shall apply for a license from the Board in accordance with
KRS
315.4102 and this administrative
regulation.
(2) A separate license
shall be required for each third-party logistics provider's facility that
provides services in the Commonwealth, including distributing into the
Commonwealth, regardless of whether joint ownership or control
exists.
(3) An agent or employee of
a licensee shall not be required to obtain a license under this section if the
agent or employee is acting in the usual course of business or
employment.
(4) A license shall not
be issued or renewed unless the applicant demonstrates or continues to
demonstrate acceptable operational procedures, including:
(a) Adequate operation, maintenance, and
storage conditions to ensure proper lighting, ventilation, temperature and
humidity control, sanitation, space, and security as per label requirements or
official United States Pharmacopoeia (USP) compendium requirements, USP Chapter
659, Packaging and Storage Requirements, as incorporated by reference in
201 KAR 2:105. Appropriate
manual, electromechanical, or electronic temperature and humidity recording
equipment, devices, or logs shall be utilized to document proper storage of
components, prescription drugs, or drug-related devices;
(b) Separation and quarantine of
deteriorated, damaged, outdated, misbranded, adulterated, or recalled
components, prescription drugs, or drug-related devices until they are
destroyed or returned; and
(c) If
applicable, provide proof of registration with the U.S. Food and Drug
Administration (FDA) and U.S. Drug Enforcement Administration (DEA) and shall
comply with all federal laws, state and local laws, and regulations.
(5) A third-party logistics
provider shall comply with all requirements as outlined in the Drug Supply
Chain Security Act (DSCSA), 21 U.S.C 360eee-360
eee-4, and other applicable federal
laws.
(6) A third-party logistics
provider shall establish a system to quarantine or destroy suspect or
illegitimate product if directed to do so by the manufacturer, repackager,
wholesale distributor, dispenser, or authorized government agency.
(7) A third-party logistics provider shall
have readily retrievable within forty-eight (48) hours, upon written request of
the board or its agents, and maintain for board inspection, a list of all
manufacturers, wholesale distributors, repackagers, and dispensers for whom the
third-party logistics provider provides services;
(8) A third-party logistics provider shall
have readily retrievable within forty-eight (48) hours, upon written request of
the board or its agents, and maintain for Board inspection, a list of each
partner, limited liability company member, corporate officer or director, and
facility manager, including a description of the duties and qualifications of
each; and
(9) A third-party
logistics provider shall have readily retrievable within forty-eight (48)
hours, upon written request of the board or its agents, and maintain for board
inspection, records with capability to trace the receipt and outbound
distribution or disposition of components, prescription drugs, or drug-related
devices and records of inventory.
Section 3. Qualifications for Licensure.
(1) The Board shall consider, at a minimum,
the following factors in determining the eligibility for initial licensure and
renewal of third-party logistics providers:
(a) Minimum considerations in
KRS
315.4106(1);
(b) Any convictions of the applicant or its
officers under any federal, state, or local laws relating to drugs, including
drug samples and controlled substances;
(c) The applicant's and its officers' past
experience with distribution of prescription drugs and drug-related devices,
including drug samples and controlled substances; and
(d) Compliance with the requirements under
any previously granted license or permit, if any.
(2) The Board may deny a license to an
applicant if it finds that the granting of that license would not be in the
public interest based on health and safety considerations.
(3) A license shall not be issued pursuant to
this administrative regulation unless the applicant has furnished proof
satisfactory to the board:
(a) That the
applicant is in compliance with all applicable federal, state, and local laws
and regulations relating to prescription drugs and drug-related devices;
and
(b) That the applicant is
equipped as to land, buildings, and security to properly conduct the business
described in the application.
(4) A license issued pursuant to this
administrative regulation failing to comply with the provisions of
KRS
315.400,
315.4102,
315.4104,
315.4106,
315.4108,
315.4110, or this administrative
regulation may result in discipline, suspension, or revocation under
KRS
315.121.
Section 4. Application, Fees, Renewals.
(1) An applicant for initial licensure or
renewal as a third-party logistics provider shall submit:
(a) A non-refundable initial licensure or
renewal fee of $400 by check or money order made payable to the Kentucky State
Treasurer;
(b) A complete, sworn,
and notarized Application to Operate as a Third-Party Logistics Provider or
Application for Third-Party Logistics Provider License Renewal;
(c) Unless previously provided, documentation
of licensure as a third-party logistics provider through proof of registration
with either:
1. The FDA; or
2. The state in which the third-party
logistics provider is located;
(d) Unless previously provided, copy of most
current inspection report conducted by the FDA. If the most current inspection
report is not available from the FDA, the applicant shall submit an inspection
report by:
1. The National Association of
Boards of Pharmacy (NABP); or
2.
The resident state licensing or permitting authority's authorized
agent;
(e) A
confirmation statement from the previous owner if ownership changed;
(f) Legal proof of any name change, if
applicable;
(g) An explanation if
an applicant, officer, partner, or director has ever been convicted of a felony
or had a professional license or permit disciplined under federal, state, or
local law;
(h) Ownership
information for each partner, director, or officer, including:
1. Name and title;
2. Email addresses;
3. Federal employer identification
number;
4. Address;
5. Phone number;
6. Social security number; and
7. Date of birth;
(i) State of incorporation or organization if
the owner is a corporation; and
(j)
Upon request, a list of all manufacturers, repackagers, wholesale distributors,
and dispensers for whom the third-party logistics provider provides
services.
(2) An
applicant applying for any ownership or address change shall submit a
non-refundable fee of $150.
(3)
Each license shall expire on June 30 following date of issuance, unless earlier
suspended or revoked. There shall be a delinquent renewal fee of $150 for
failure to renew by June 30 of each year.
Section 5. Standards.
(1) Facilities.
(a) All facilities in which components,
prescription drugs, or drug-related devices are held shall be of suitable size,
construction, and location to facilitate cleaning, maintenance, and proper
operations;
(b) All facilities
shall meet all applicable federal, state, and local laws and
regulations;
(c) A third-party
logistics provider shall quarantine components, prescription drugs, or
drug-related devices that are outdated, damaged, deteriorated, misbranded,
recalled, or adulterated;
(d) A
facility shall not be located in a residence; and
(e) A facility shall be located apart and
separate from any pharmacy permitted by the Board.
(2) Security.
(a) A third-party logistics provider shall be
equipped with an alarm system to detect entry after hours.
(b) A third-party logistics provider shall
assure that access from outside the provider's premises is well controlled and
reduced to a minimum. This includes the installation of adequate lighting at
the outside perimeter of the premises.
(c) Internal security policies shall be
developed to provide reasonable protection against theft and diversion by
limiting access to areas where components, prescription drugs, or drug-related
devices are held to authorized personnel. These policies shall provide
protection against tampering with computers or electronic records.
(d) A third-party logistics provider shall
employ adequate personnel with the education and experience necessary to safely
and lawfully engage in providing these services.
(3) Recordkeeping requirements for companies
handling prescription drugs and drug-related devices exempt from the DSCSA.
(a) Inventories and other records regarding
the receipt and distribution or disposition of components, prescription drugs,
or drug-related devices shall be maintained and readily retrievable within
forty-eight (48) hours for inspection or photocopying by the Board and
authorized officials of any federal, state or local law enforcement agencies
for a period of six (6) years. These records shall include:
1. The business name and address of the
third-party logistics provider's client and the address of the location from
which the components, prescription drugs, or drug-related devices were
received;
2. The business name and
address to whom the components, prescription drugs, or drug-related devices
were distributed or disposed of;
3.
The identity and quantity of the components, prescription drugs, or
drug-related devices received and distributed or disposed of; and
4. The dates of receipt and distribution or
disposition of the components, prescription drugs, or drug-related
devices.
(b) Records
described in this section that are kept at the inspection site or that may be
immediately retrieved by computer or other electronic means shall be readily
available for authorized inspection during the retention period. Records kept
at a central location apart from the inspection site and not electronically
retrievable shall be made available for inspection within two (2) working days
of a request by the Board or an authorized official of any federal, state or
local law enforcement agency.
(c)
Third-party logistics providers shall maintain an ongoing list of verified
persons or businesses to whom they ship prescription drugs and drug-related
devices.
(d) Third-party logistics
providers may distribute components, prescription drugs, or drug-related
devices only to the following, except as established in
KRS
315.0351(2) and
315.404:
1. A currently permitted
manufacturer:
2. A currently
licensed wholesaler;
3. A currently
licensed third party logistics provider;
4. A currently permitted pharmacy;
5. A currently licensed outsourcing
facility;
6. A currently licensed
practitioner;
7. A currently
permitted repackager;
8. A
currently licensed hospital, but only for use by or in that hospital;
9. A person in charge of a laboratory, but
only for use in that laboratory for scientific and medical research purposes;
or
10. Any other appropriately
licensed or permitted facility in the jurisdiction in which it is
located.
(4)
Written policies and procedures.
(a) A
third-party logistics provider shall establish, maintain, and adhere to written
policies and procedures for the receipt, security, storage, inventory, and
distribution or disposition of components, prescription drugs, or drug-related
devices.
(b) There shall be written
policies and procedures for identifying, recording, and reporting significant
losses or thefts to the Board, and, if applicable, the FDA and the
DEA.
(c) There shall be written
policies and procedures for protecting against, and handling crisis situations
that affect the security or operation of the facility. These crises shall
include fires, floods, or other natural disasters, and situations of local,
state, or national emergency.
(d)
There shall be written policies and procedures for managing and correcting all
errors or inaccuracies in inventories.
(e) There shall be written policies and
procedures as to the handling of any outdated, returned, or damaged
prescription drugs and drug-related devices. Any outdated, returned, or damaged
components, prescription drugs, or drug-related devices shall be
segregated.
(f) There shall be
written policies and procedures by which the third-party logistics provider
exercises control over the shipping and receiving of all components,
prescription drugs, or drug-related devices within the operation.
(g) There shall be written policies and
procedures for quarantining suspect product and illegitimate product if
directed to do so by the respective manufacturer, repackager, wholesale
distributor, dispenser, or authorized government agency.
(5) Handling recalls. A third-party logistics
provider shall establish, maintain, and adhere to a written policy and
procedure in accordance with business agreements as to the handling of recalls
and withdrawals of components, prescription drugs, or drug-related
devices.
Section 6.
Violations.
(1) A third-party logistics
provider shall not distribute components, prescription drugs, or drug-related
devices directly to a consumer or a patient, except as established in
KRS
315.0351(2).
(2) A third-party logistics provider shall
not operate in a manner that endangers the public health.
(3) Violations of any of these provisions
shall be grounds for action under
KRS
315.121.
Section 7. Incorporation by Reference.
(1) The following material is incorporated by
reference:
(a) "Application to Operate as a
Third-Party Logistics Provider", June 2023; and
(b) "Application For Third-Party Logistics
Provider License Renewal", June 2023.
(2) This material may be inspected, copied,
or obtained, subject to applicable copyright law, at the Kentucky Board of
Pharmacy, State Office Building Annex, Suite 300, 125 Holmes Street, Frankfort,
Kentucky 40601-8024, Monday through Friday, 8:00 a.m. to 4:30 p.m. This
material is also available on the Board's Web site at
https://pharmacy.ky.gov/Businesses/Pages/Third-Party-Logistics-Provider-License-Information.aspx.
STATUTORY AUTHORITY:
KRS
315.191(1)(a),
315.4102,
315.4104,
315.4106,
315.4108,
315.4110